Exploratory study on autoantibodies to arginine-rich human peptides mimicking Epstein-Barr virus in women with post-COVID and myalgic encephalomyelitis/chronic fatigue syndrome. — CFSMEATLAS
Exploratory study on autoantibodies to arginine-rich human peptides mimicking Epstein-Barr virus in women with post-COVID and myalgic encephalomyelitis/chronic fatigue syndrome.
Hoheisel, Friederike, Fleischer, Kathrin Maria, Rubarth, Kerstin et al. · Frontiers in immunology · 2025 · DOI
Quick Summary
This study looked for certain antibodies in the blood of women with post-COVID and ME/CFS that might mistakenly attack the body's own proteins. The researchers found that patients with these conditions had more of these problematic antibodies than healthy people, and these antibodies were linked to common ME/CFS symptoms like fatigue, brain fog, pain, and autonomic problems. The results suggest that a virus (EBV) may trigger the immune system to attack human proteins that look similar to viral proteins.
Why It Matters
This research provides evidence for a potential mechanism—molecular mimicry—that could explain how viral infections trigger ME/CFS and post-COVID in some patients. Understanding this autoimmune mechanism could eventually lead to better diagnostic tests and targeted treatments for these debilitating conditions.
Observed Findings
Autoantibodies to poly-R sequences in SRRM3, SLC24A3, TSPLY2, and TSPYL5 were significantly more frequent in patient groups compared to healthy controls.
Autoantibodies against full-length ADRA proteins were more frequently detected in PCS and ME/CFS patients.
Several autoantibodies showed positive correlations with core ME/CFS symptoms including autonomic dysfunction, fatigue, cognitive impairment, and pain.
Both post-COVID patients alone and those meeting ME/CFS criteria showed elevated autoantibody responses.
The target proteins identified are involved in neuronal function, ion transport, and vascular regulation.
Inferred Conclusions
EBV-derived arginine-rich peptide sequences may trigger cross-reactive autoantibodies against structurally similar human proteins through molecular mimicry.
Autoimmune mechanisms targeting neuronal, ion channel, and regulatory proteins may contribute to ME/CFS and post-COVID pathogenesis.
The association between specific autoantibodies and symptom profiles suggests potential biomarkers for disease characterization.
Remaining Questions
Do these autoantibodies have a causal role in producing symptoms, or are they epiphenomena of the disease process?
What This Study Does Not Prove
This study does not prove that these autoantibodies cause ME/CFS or post-COVID; it only shows they are more common in patients with these conditions. The results cannot be generalized to men, and the correlations with symptoms don't establish that the autoantibodies directly cause the symptom severity—other factors may be involved.